Personal information

No personal information available

Activities

Works (3)

Industry Perspective on Therapeutic Peptide Drug–Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper

Clinical Pharmacology & Therapeutics
2023-06 | Journal article
Contributors: Carolina Säll; Upendra Argikar; Kari Fonseca; Constanze Hilgendorf; Filipe Lopes; Jens Riedel; Hilmar Schiller; Anders Sonesson; Kenichi Umehara; Kai Wang
Source: check_circle
Crossref

Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development

Clinical Pharmacology & Therapeutics
2023-06 | Journal article
Contributors: David E. Coutant; David W. Boulton; Upendra P. Dahal; Antoine Deslandes; Christine Grimaldi; Joao N.S. Pereira; Carolina Säll; Hetal Sarvaiya; Hilmar Schiller; Guoying Tai et al.
Source: check_circle
Crossref

Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions

European Journal of Pharmaceutical Sciences
2022-05 | Journal article
Contributors: Hilmar Schiller; Felix Huth; Carole Schuhler; Anton Drollmann; Martin Kaul; Ralph Woessner; Bharti Shah; Wendy Weis; Peter End
Source: check_circle
Crossref